Davis C Woodworth1,2, Hannah L Nguyen3, Zainab Khan3, Claudia H Kawas1,2,4, María M Corrada1,2,4,5, S Ahmad Sajjadi1,2. 1. Department of Neurology, University of California, Orange, California, USA. 2. Institute for Memory Impairments and Neurological Disorders, University of California, Irvine, California, USA. 3. Department of Biological Sciences, University of California, Irvine, California, USA. 4. Department of Neurobiology and Behavior, University of California, Irvine, California, USA. 5. Department of Epidemiology, University of California, Irvine, California, USA.
Abstract
INTRODUCTION: Hippocampal sclerosis of aging (HS) is a common pathology often misdiagnosed as Alzheimer's disease. We tested the hypothesis that participants with HS would have a magnetic resonance imaging (MRI)-detectable hippocampal pattern of atrophy distinct from participants without HS, both with and without Alzheimer's disease neuropathology (ADNP). METHODS: Query of the National Alzheimer's Coordinating Center database identified 198 participants with MRI and autopsy. Hippocampal subfields were segmented with FreeSurfer v6. Analysis of covariance for subfield volumes compared HS+ participants to those without HS, both with ADNP (HS-/ADNP+) and without (HS-/ADNP-). RESULTS: HS+ participants (N = 27, 14%) showed atrophied cornu ammonis 1 (CA1; left P < .001, ηp 2 = 0.14; right P = .001, ηp 2 = 0.09) and subiculum (left P < .001, ηp 2 = 0.139; right P = .001, ηp 2 = 0.085) compared to HS-/ADNP+ (N = 100, 51%). Compared to HS-/ADNP- (N = 71, 36%), HS+ also had atrophy in subiculum (left P < .001, ηp 2 = 0.235; right P = .002, ηp 2 = 0.137) and CA1 (left P < .001, ηp 2 = 0.137; right P = .006, ηp 2 = 0.070). DISCUSSION: Subiculum and CA1 atrophy from clinical MRI may be a promising in vivo biomarker for HS.
INTRODUCTION: Hippocampal sclerosis of aging (HS) is a common pathology often misdiagnosed as Alzheimer's disease. We tested the hypothesis that participants with HS would have a magnetic resonance imaging (MRI)-detectable hippocampal pattern of atrophy distinct from participants without HS, both with and without Alzheimer's disease neuropathology (ADNP). METHODS: Query of the National Alzheimer's Coordinating Center database identified 198 participants with MRI and autopsy. Hippocampal subfields were segmented with FreeSurfer v6. Analysis of covariance for subfield volumes compared HS+ participants to those without HS, both with ADNP (HS-/ADNP+) and without (HS-/ADNP-). RESULTS: HS+ participants (N = 27, 14%) showed atrophied cornu ammonis 1 (CA1; left P < .001, ηp 2 = 0.14; right P = .001, ηp 2 = 0.09) and subiculum (left P < .001, ηp 2 = 0.139; right P = .001, ηp 2 = 0.085) compared to HS-/ADNP+ (N = 100, 51%). Compared to HS-/ADNP- (N = 71, 36%), HS+ also had atrophy in subiculum (left P < .001, ηp 2 = 0.235; right P = .002, ηp 2 = 0.137) and CA1 (left P < .001, ηp 2 = 0.137; right P = .006, ηp 2 = 0.070). DISCUSSION: Subiculum and CA1 atrophy from clinical MRI may be a promising in vivo biomarker for HS.
Authors: Juan Eugenio Iglesias; Jean C Augustinack; Khoa Nguyen; Christopher M Player; Allison Player; Michelle Wright; Nicole Roy; Matthew P Frosch; Ann C McKee; Lawrence L Wald; Bruce Fischl; Koen Van Leemput Journal: Neuroimage Date: 2015-04-29 Impact factor: 6.556
Authors: Duane L Beekly; Erin M Ramos; Gerald van Belle; Woodrow Deitrich; Amber D Clark; Mary E Jacka; Walter A Kukull Journal: Alzheimer Dis Assoc Disord Date: 2004 Oct-Dec Impact factor: 2.703
Authors: K A Josephs; J L Whitwell; D S Knopman; W T Hu; D A Stroh; M Baker; R Rademakers; B F Boeve; J E Parisi; G E Smith; R J Ivnik; R C Petersen; C R Jack; D W Dickson Journal: Neurology Date: 2008-04-09 Impact factor: 9.910
Authors: Clifford R Jack; Matt A Bernstein; Nick C Fox; Paul Thompson; Gene Alexander; Danielle Harvey; Bret Borowski; Paula J Britson; Jennifer L Whitwell; Chadwick Ward; Anders M Dale; Joel P Felmlee; Jeffrey L Gunter; Derek L G Hill; Ron Killiany; Norbert Schuff; Sabrina Fox-Bosetti; Chen Lin; Colin Studholme; Charles S DeCarli; Gunnar Krueger; Heidi A Ward; Gregory J Metzger; Katherine T Scott; Richard Mallozzi; Daniel Blezek; Joshua Levy; Josef P Debbins; Adam S Fleisher; Marilyn Albert; Robert Green; George Bartzokis; Gary Glover; John Mugler; Michael W Weiner Journal: J Magn Reson Imaging Date: 2008-04 Impact factor: 4.813
Authors: Willa D Brenowitz; Sarah E Monsell; Frederick A Schmitt; Walter A Kukull; Peter T Nelson Journal: J Alzheimers Dis Date: 2014 Impact factor: 4.472
Authors: Mia Kero; Anna Raunio; Tuomo Polvikoski; Pentti J Tienari; Anders Paetau; Liisa Myllykangas Journal: J Alzheimers Dis Date: 2018 Impact factor: 4.472
Authors: Davis C Woodworth; Kiana A Scambray; María M Corrada; Claudia H Kawas; S Ahmad Sajjadi Journal: J Alzheimers Dis Date: 2021 Impact factor: 4.472
Authors: Davis C Woodworth; Nasim Sheikh-Bahaei; Kiana A Scambray; Michael J Phelan; Mari Perez-Rosendahl; María M Corrada; Claudia H Kawas; Seyed Ahmad Sajjadi Journal: Brain Commun Date: 2022-03-07